Are teicoplanin-non-susceptible Staphylococcus epidermidis strains increasing?

Researchers elucidated the incidence patterns of teicoplanin-non-susceptible Staphylococcus epidermidis (Teico-NS S. epidermidis) over six years.

The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase–negative staphylococci strains: a systematic review and meta-analysis

Extensive remodelling of the cell wall during the development of Staphylococcus aureus bacteraemia

Emerging vancomycin-non susceptible coagulase negative Staphylococci associated with skin and soft tissue infections, Annals of Clinical Microbiology and Antimicrobials

Frontiers Prevalence, Genetic Diversity, and Temporary Shifts of Inducible Clindamycin Resistance Staphylococcus aureus Clones in Tehran, Iran: A Molecular–Epidemiological Analysis From 2013 to 2018

Vancomycin-Intermediate Staphylococcus epidermidis: Curio or Omen?, Infection Control & Hospital Epidemiology

Epidemiological profiles and pathogenicity of Vancomycin-resistant Enterococcus faecium clinical isolates in Taiwan [PeerJ]

High Prevalence of Teicoplanin Resistance among Staphylococcus epidermidis Strains in a 5-Year Retrospective Study

Increased incidence of teicoplanin-non-susceptible Staphylococcus epidermidis strains: a 6-year retrospective study

Extensive remodelling of the cell wall during the development of Staphylococcus aureus bacteraemia

Antibiotics, Free Full-Text

ClinMed International Library, Development of Teicoplanin Tolerance by Staphylococcus epidermidis and Increased Susceptibility to Bacteriophage Type 92 by Methicillin-Resistant Staphylococcus aureus in Polymicrobial Biofilms

Full article: Increasing prevalence of hypervirulent ST5 methicillin susceptible Staphylococcus aureus subtype poses a serious clinical threat

Methicillin-resistant Staphylococcus aureus - Wikipedia